Clinical Trial Update: Systemic Hormones and Muscle Protein Synthesis [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial investigating systemic hormones for muscle protein synthesis in sarcopenia and related muscle wasting conditions.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Muscle Atrophy
• Muscle Hypotrophy
• Sarcopenia

Snippet

Sponsor: University of Nottingham | Conditions: Sarcopenia, Muscle Hypotrophy | Phase 3 | Status: UNKNOWN